Alcon has seen its share price grind lower in recent years, which naturally puts a spotlight on whether the current valuation ...

Alcon (ISIN CH0432492467) stock was trading at EUR 56.87 at Lang & Schwarz on October 2, 2026 at 12:15 p.m. CEST, down 0.04 ...

CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent innovation launches, citing ...

According to MarketBeat, Alcon reported USD 0.84 earnings per share for the quarter announced on August 10, 2026, exceeding ...

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of Systane® PRO Preservative-Free (PF) in Canada as Systane's most advanced formula.

Geneva, Switzerland-based Alcon and Orlando, FL-based Lensar have entered a merger agreement through which Alcon intends to acquire Lensar. The acquisition includes the Ally robotic cataract laser ...

FORT WORTH, Texas, September 29, 2026 - Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it will present new scientific research and ...

Alcon innovations featured in more than 75 abstracts across cataract, refractive, visualization and ocular health1 Clinical data presentations and sponsored symposia to highlight the efficacy of Alcon ...